Respiratory syncytial virus infection+3
Not yet recruitingImmune response and safety of revaccination with respiratory syncytial virus glycoprotein F recombinant vaccine adjuvanted with AS01E in older adults
Immune response and safety of revaccination with respiratory syncytial virus glycoprotein F recombinant vaccine adjuvanted with AS01E in older adults
- Disease:Respiratory syncytial virus infectionRespiratory syncytial virus bronchiolitis+2
- Substances:GSKVx000000017064
Belgium- Participants:65+ years · Healthy volunteers
- Substances:GSKVx000000017064
- Sponsor:GlaxoSmithKline Biologicals









